January 19, 2024
Family-owned medtech firm Biotronik appoints Goldman Sachs for a potential sale of their Vascular intervention (stent) business with EUR 55-60m in adjusted EBITDA, with the contemplations still in early days, according to multiple sources (NKP Proprietary)
NKP | M&A Insights Proprietary
Headline from pre-deal coverage in M&A Insights
.png){kind=logo}